{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Contamination radioactive des aliments : Questions médicales les plus fréquentes",
"headline": "Contamination radioactive des aliments : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Contamination radioactive des aliments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-03",
"dateModified": "2025-03-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Contamination radioactive des aliments"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hygiène radiologique",
"url": "https://questionsmedicales.fr/mesh/D011870",
"about": {
"@type": "MedicalCondition",
"name": "Hygiène radiologique",
"code": {
"@type": "MedicalCode",
"code": "D011870",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.810"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Contamination radioactive des aliments",
"alternateName": "Food Contamination, Radioactive",
"code": {
"@type": "MedicalCode",
"code": "D005507",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "I Ye Kolpakov",
"url": "https://questionsmedicales.fr/author/I%20Ye%20Kolpakov",
"affiliation": {
"@type": "Organization",
"name": "State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine."
}
},
{
"@type": "Person",
"name": "V Yu Vdovenko",
"url": "https://questionsmedicales.fr/author/V%20Yu%20Vdovenko",
"affiliation": {
"@type": "Organization",
"name": "State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine."
}
},
{
"@type": "Person",
"name": "Ryszard Misiak",
"url": "https://questionsmedicales.fr/author/Ryszard%20Misiak",
"affiliation": {
"@type": "Organization",
"name": "Institute of Nuclear Physics, Polish Academy of Sciences, Radzikowskiego 152, 31-342 Kraków, Poland."
}
},
{
"@type": "Person",
"name": "Yuki Sato",
"url": "https://questionsmedicales.fr/author/Yuki%20Sato",
"affiliation": {
"@type": "Organization",
"name": "Collaborative Laboratories for Advanced Decommissioning Science, Japan Atomic Energy Agency, 790-1 Motooka aza Ohtsuka, Tomioka-machi, Futaba-gun, Fukushima, Japan. Electronic address: sato.yuki@jaea.go.jp."
}
},
{
"@type": "Person",
"name": "Vladimir Drozdovitch",
"url": "https://questionsmedicales.fr/author/Vladimir%20Drozdovitch",
"affiliation": {
"@type": "Organization",
"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7E548 MSC 9778, Bethesda, MD, 20892-9778, USA. drozdovv@mail.nih.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The relevance of EGFR, ErbB receptors and neuregulins in human adipocytes and adipose tissue in obesity.",
"datePublished": "2022-11-09",
"url": "https://questionsmedicales.fr/article/36411648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2022.113972"
}
},
{
"@type": "ScholarlyArticle",
"name": "Non-equilibrium modalities of inhibition: Characterizing irreversible inhibition for the ErbB receptor family members.",
"datePublished": "2023-09-01",
"url": "https://questionsmedicales.fr/article/37858541",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.mie.2023.08.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of ErbB Receptors by the Ca",
"datePublished": "2023-02-22",
"url": "https://questionsmedicales.fr/article/36979639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biomedicines11030661"
}
},
{
"@type": "ScholarlyArticle",
"name": "iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.",
"datePublished": "2022-09-08",
"url": "https://questionsmedicales.fr/article/35971826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/jcs.259949"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35667295",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.oraloncology.2022.105939"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hygiène radiologique",
"item": "https://questionsmedicales.fr/mesh/D011870"
},
{
"@type": "ListItem",
"position": 5,
"name": "Contamination radioactive des aliments",
"item": "https://questionsmedicales.fr/mesh/D005507"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Contamination radioactive des aliments - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Contamination radioactive des aliments",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Contamination radioactive des aliments",
"description": "Comment détecte-t-on la contamination radioactive des aliments ?\nQuels sont les indicateurs de contamination radioactive ?\nLes inspections alimentaires incluent-elles la radioactivité ?\nQuels appareils mesurent la radioactivité dans les aliments ?\nPeut-on détecter la radioactivité par des méthodes visuelles ?",
"url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=ErbB+Receptors#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Contamination radioactive des aliments",
"description": "Quels symptômes indiquent une exposition à des aliments radioactifs ?\nLa contamination radioactive cause-t-elle des maladies ?\nLes symptômes apparaissent-ils immédiatement après ingestion ?\nY a-t-il des symptômes spécifiques pour les enfants ?\nComment la radioactivité affecte-t-elle le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=ErbB+Receptors#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Contamination radioactive des aliments",
"description": "Comment prévenir la contamination radioactive des aliments ?\nLes contrôles de sécurité alimentaire sont-ils efficaces ?\nQuelles sont les recommandations pour les agriculteurs ?\nLes consommateurs peuvent-ils réduire les risques ?\nLes étiquettes alimentaires indiquent-elles la radioactivité ?",
"url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=ErbB+Receptors#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Contamination radioactive des aliments",
"description": "Quel traitement existe pour la contamination radioactive ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nPeut-on utiliser des médicaments pour réduire les effets ?\nLa décontamination des aliments est-elle possible ?\nQuels sont les soins post-exposition recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=ErbB+Receptors#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Contamination radioactive des aliments",
"description": "Quelles complications peuvent survenir après exposition ?\nLa contamination radioactive affecte-t-elle la reproduction ?\nLes effets de la radioactivité sont-ils réversibles ?\nY a-t-il des risques pour les générations futures ?\nComment la radioactivité affecte-t-elle la santé mentale ?",
"url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=ErbB+Receptors#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Contamination radioactive des aliments",
"description": "Quels sont les principaux facteurs de risque de contamination ?\nLes aliments importés présentent-ils un risque ?\nLes conditions climatiques influencent-elles la contamination ?\nLes populations vulnérables sont-elles plus à risque ?\nL'alimentation biologique est-elle plus sûre ?",
"url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=ErbB+Receptors#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on la contamination radioactive des aliments ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de radiométrie et des analyses de laboratoire sont utilisés pour détecter la radioactivité."
}
},
{
"@type": "Question",
"name": "Quels sont les indicateurs de contamination radioactive ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de radiation mesurés en becquerels par kilogramme d'aliment sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Les inspections alimentaires incluent-elles la radioactivité ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les inspections peuvent inclure des tests pour la radioactivité dans les aliments."
}
},
{
"@type": "Question",
"name": "Quels appareils mesurent la radioactivité dans les aliments ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des détecteurs de radiation et des spectromètres gamma sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la radioactivité par des méthodes visuelles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radioactivité ne peut pas être détectée visuellement; des instruments spécifiques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition à des aliments radioactifs ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure nausées, vomissements, fatigue et troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "La contamination radioactive cause-t-elle des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des maladies graves, y compris des cancers."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils immédiatement après ingestion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours; certains effets peuvent prendre des jours ou des mois à se manifester."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques pour les enfants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent être plus sensibles et présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Comment la radioactivité affecte-t-elle le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut affaiblir le système immunitaire, rendant l'individu plus vulnérable aux infections."
}
},
{
"@type": "Question",
"name": "Comment prévenir la contamination radioactive des aliments ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les zones contaminées et suivre les recommandations des autorités sanitaires."
}
},
{
"@type": "Question",
"name": "Les contrôles de sécurité alimentaire sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers aident à détecter et prévenir la contamination radioactive."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les agriculteurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'utilisation d'eau contaminée et surveiller les niveaux de radiation dans le sol."
}
},
{
"@type": "Question",
"name": "Les consommateurs peuvent-ils réduire les risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en choisissant des aliments provenant de sources sûres et en suivant les alertes sanitaires."
}
},
{
"@type": "Question",
"name": "Les étiquettes alimentaires indiquent-elles la radioactivité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radioactivité n'est généralement pas indiquée sur les étiquettes alimentaires."
}
},
{
"@type": "Question",
"name": "Quel traitement existe pour la contamination radioactive ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des agents chélateurs pour éliminer les radionucléides du corps."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins d'urgence peuvent être nécessaires pour traiter les symptômes aigus."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des médicaments pour réduire les effets ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent aider à atténuer certains effets, mais ne neutralisent pas la radioactivité."
}
},
{
"@type": "Question",
"name": "La décontamination des aliments est-elle possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, une fois contaminés, les aliments radioactifs ne peuvent pas être décontaminés efficacement."
}
},
{
"@type": "Question",
"name": "Quels sont les soins post-exposition recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillance médicale et tests réguliers pour détecter d'éventuels effets à long terme."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des cancers, des maladies thyroïdiennes et des troubles immunitaires."
}
},
{
"@type": "Question",
"name": "La contamination radioactive affecte-t-elle la reproduction ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des problèmes de fertilité et des malformations congénitales."
}
},
{
"@type": "Question",
"name": "Les effets de la radioactivité sont-ils réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres, comme le cancer, peuvent ne pas l'être."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les générations futures ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la contamination peut avoir des effets héréditaires sur les générations futures."
}
},
{
"@type": "Question",
"name": "Comment la radioactivité affecte-t-elle la santé mentale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut causer de l'anxiété, du stress et des troubles psychologiques chez les exposés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de contamination ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les zones proches de centrales nucléaires et les sites d'accidents nucléaires sont à risque."
}
},
{
"@type": "Question",
"name": "Les aliments importés présentent-ils un risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments importés peuvent être contaminés, surtout en provenance de zones à risque."
}
},
{
"@type": "Question",
"name": "Les conditions climatiques influencent-elles la contamination ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements comme les pluies acides peuvent augmenter la contamination des sols et des cultures."
}
},
{
"@type": "Question",
"name": "Les populations vulnérables sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants, les femmes enceintes et les personnes immunodéprimées sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "L'alimentation biologique est-elle plus sûre ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement; la contamination peut affecter tous les types d'aliments, y compris biologiques."
}
}
]
}
]
}
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine.
Publications dans "Contamination radioactive des aliments" :
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine.
Publications dans "Contamination radioactive des aliments" :
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7E548 MSC 9778, Bethesda, MD, 20892-9778, USA. drozdovv@mail.nih.gov.
Publications dans "Contamination radioactive des aliments" :
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine.
Publications dans "Contamination radioactive des aliments" :
Office of Research and Development, Center for Environmental Solutions and Emergency Response, U.S. Environmental Protection Agency, 26 W. Martin Luther King Drive, Cincinnati, OH, 45268, USA.
Publications dans "Contamination radioactive des aliments" :
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka Str., Kyiv, 04050, Ukraine.
Publications dans "Contamination radioactive des aliments" :
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka Str., Kyiv, 04050, Ukraine.
Publications dans "Contamination radioactive des aliments" :
To investigate the potential role of EGFR, ErbBs receptors and neuregulins in human adipose tissue physiology in obesity....
Gene expression analysis in human subcutaneous (SAT) and visceral (VAT) adipose tissue in three independent cohorts [two cross-sectional (N = 150, N = 87) and one longitudinal (n = 25)], and in vitro ...
While both SAT and VAT ERBB2 and ERBB4 mRNA increased in obesity, SAT EGFR mRNA was negatively correlated with insulin resistance, but did not change in obesity. Of note, both SAT and VAT EGFR mRNA we...
This study demonstrates the association between adipose tissue ERBB2 and obesity, confirms the relevance of EGFR on human adipogenesis, and suggests a possible adipogenic role of NRG2....
Most drug target interactions for clinically approved small-molecules are non-equilibrium slow-onset, tight-binding or irreversible in nature, with pronounced element of time-dependence of inhibition....
Overexpression and mutations of the epidermal growth factor receptor (EGFR/ErbB1/HER1) and other tyrosine kinase receptors of the ErbB family (ErbB2/HER2, ErbB3/HER3 and ErbB4/HER4) play an essential ...
Dysregulation of the ERBB/EGFR signalling pathway causes multiple types of cancer. Accordingly, ADAM17, the primary shedding enzyme that releases and activates ERBB ligands, is tightly regulated. It h...
To identify the most effective PI3K and EGFR inhibitors in HPV-positive head and neck squamous cell carcinoma (HNSCC) and investigate the efficacy of a combination of an ErbB family kinase inhibitor a...
HPV-positive HNSCC cell lines were treated with the FDA approved ErbB kinase inhibitor, Afatinib or FDA-approved PI3K inhibitor, Copanlisib, alone or in combination, and phosphorylation and total prot...
Copanlisib more effectively inhibited cell proliferation in comparison to other PI3K inhibitors tested. HPV-positive HNSCC cells differentially responded to cisplatin, Afatinib, or Copanlisib. The com...
Afatinib and Copanlisib more effectively suppress cell proliferation and survival of HPV-positive HNSCC in comparison to either treatment alone....
This phase I/expansion study assessed the safety, pharmacokinetics and preliminary antitumor activity of afatinib in paediatric patients with cancer....
The dose-finding part enroled patients (2-<18 years) with recurrent/refractory tumours. Patients received 18 or 23 mg/m...
Of 564 patients pre-screened, 536 patients had biomarker data and 63 (12%) fulfilled ≥2 EGFR/HER2 criteria required for inclusion in the expansion part. A total of 56 patients were treated (17 in the ...
Targetable EGFR/HER2 drivers are rare in paediatric cancers. Treatment with afatinib led to a durable response (>3 years) in one patient with a glioneuronal tumour with CLIP2::EGFR fusion....
The ErbB RTKs (EGFR, HER2, HER3, and HER4) have been well-studied in cancer. EGFR, HER2, and HER3 stimulate cancer proliferation, principally by activating the phosphatidylinositol-3-kinase and extrac...
In general, human meningiomas grow slowly and have a favourable prognosis; however, some are prone to recur despite their benign histology. Therefore, knowledge of their tumour biology is essential to...
Targeting the HER2 oncogene represents one of the greatest advances in the treatment of breast cancer. HER2 is one member of the ERBB-receptor family, which includes EGFR (HER1), HER3 and HER4. In the...
Hepatocellular carcinoma (HCC) poses a significant global health challenge due to its poor prognosis and limited therapeutic modalities. Anoikis and ErbB signaling pathways are pivotal in cancer cell ...
This study evaluates the prognostic significance of anoikis and ErbB signaling pathways in HCC by utilizing data from The Cancer Genome Atlas (TCGA), the International Cancer Genome Consortium (ICGC),...
The single sample Gene Set Enrichment Analysis revealed a strong correlation between upregulated ErbB signaling in high anoikis-expressing tumors and poor clinical outcomes. The development of the Ano...
AERS provides a novel tool for clinical prognosis and paves the way for immune-targeted therapeutic approaches, underscoring the potential of integrated molecular profiling in enhancing treatment stra...